Skip to main content
Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Publisher: Bentham Science Publishers

More about this publication?
Volume 21, Number 26, 2015

Articles

Open Access Meet Our Editorial Board Member:
pp. 3697-3697(1)
Author: A. Butterfield, D.

Favourites:
ADD
Favourites:
ADD

Bitropic D3 Dopamine Receptor Selective Compounds s Potential Antipsychotics
pp. 3700-3724(25)
Authors: R. Luedtke, Robert; Rangel-Barajas, Claudia; Malik, Mahinder; E. Reichert, David; H. Mach, R.

Favourites:
ADD

Serotonin 5-HT1A Receptors and Antipsychotics - An Update in Light of New Concepts and Drugs
pp. 3725-3731(7)
Authors: C. McCreary, Andrew; Newman-Tancredi, Adrian

Favourites:
ADD

Atypical antipsychotics and inverse agonism at 5-HT2 receptors
pp. 3732-3738(7)
Authors: C. Sullivan, Laura; P Clarke, William; A. Berg, Kelly

Favourites:
ADD

5-HT6 Receptor Antagonists: Potential Efficacy for the Treatment of Cognitive Impairment in Schizophrenia
pp. 3739-3759(21)
Authors: M.W.J. de Bruin, Natasja; G Kruse, Chris

Favourites:
ADD

Do Histamine receptor 3 antagonists have a place in the therapy for schizophrenia?
pp. 3760-3770(11)
Authors: A. Ellenbroek, Bart; Ghiabi, Bibinaz

Favourites:
ADD

Inhibition of glycine transporter 1: The yellow brick road to new schizophrenia therapy?
pp. 3771-3787(17)
Authors: Singer, Philipp; Dubroqua, Sylvain; K. Yee, Benjamin

Favourites:
ADD
Favourites:
ADD
Favourites:
ADD

Treatment of Cognitive Impairment in Schizophrenia: Potential Value of Phosphodiesterase Inhibitors in Prefrontal Dysfunction
pp. 3813-3828(16)
Authors: Van Duinen, Marlies; A.H. Reneerkens, Olga; Lambrecht, Lena; Sambeth, Anke; P.F. Rutten, Bart; Van Os, Jim; Blokland, Arjan; Prickaerts, Jos

Favourites:
ADD

Atrial Fibrillation and Gastro-Oesophageal Reflux Disease - Controversies and Challenges
pp. 3829-3834(6)
Authors: Floria, Mariana; Barboi, Oana; Rezus, Ciprian; Ambarus, Valentin; Cijevschi-Prelipcean, Cristina; Balan, Gheorghe; Liviu Drug, Vasile

Favourites:
ADD

Efficacy of Andolast in Mild to Moderate Asthma: A Randomized, Controlled, Double-Blind Multicenter Study (The Andast Trial)
pp. 3835-3843(9)
Authors: Malerba, Mario; D`Amato, Massimo; Radaeli, Alessandro; Giacovelli, Giampaolo; Rovati, Lucio; H. Arshad, Sayed; T. Holgate, Stephen

Favourites:
ADD
Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content